A Novel Molecule of the Angiotensin II Receptor Blocker Class: Focus on Olmesartan Medoxomil

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 2, 2005-01 ,pp. : 79-89

Adis International

Access to resources Recommend Favorite

Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

By Brillante Divina Gracilla   O'Sullivan Anthony John   Brillante Ruby Esmeralda   Howes Laurence Guy  

Blood Pressure, Vol. 18, Iss. 3, 2009-06 ,pp. : 142-148

Informa Healthcare

Access to resources Recommend Favorite

Unconventional Signalling Mechanisms Mediated by the Angiotensin II Type 1 Receptor in Cardiovascular Cell Types

By Zhai Peiyong   Galeotti Jonathan   Sadoshima Junichi  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 4, 2006-01 ,pp. : 143-150

Adis International

Access to resources Recommend Favorite

The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice

By Masamune Atsushi   Hamada Shin   Kikuta Kazuhiro   Takikawa Tetsuya   Miura Shin   Nakano Eriko   Shimosegawa Tooru  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 5, 2013-05 ,pp. : 602-609

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II Blockade and Total Cardiovascular Risk: Beyond Blood Pressure Reduction

By Cipollone Francesco   Sara Di Fabio   Bucci Marco   Cicolini Giancarlo   Mezzetti Andrea  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 4, 2008-01 ,pp. : 245-253

Adis International

Access to resources Recommend Favorite